Leveraging the Laboratory: Vision to Action - Insights
Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.
Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the...
New Years Holiday Shipment Schedules - Insights
The United States will observe the New Year holiday on Monday, Jan. 1. On this day, Mayo Clinic Laboratories will be open; however, specimen shipments and deliveries to our laboratories will not be made by the carriers. To safeguard...
New tests launched in February - Insights
In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Dr. Morice Shares Trends and Predictions for 2025 - Insights
The healthcare and diagnostics landscape is poised for transformative changes driven by technological advancements and evolving market dynamics.
Lab medicine is an ever-evolving field, and staying up to date can be a challenge. Mayo Clinic Laboratories' podcasts are designed to share the information you need to know about the latest developments in laboratory diagnostics.
The Resources page features a compilation of valuable education and content not specific to a program type.
Laboratory/Patient Safety/Quality Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide targeted cancer surveillance for...
Breast cancer panel halves turnaround time: Wei Shen, Ph.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Wei Shen, Ph.D., explains how Mayo Clinic Laboratories' new breast cancer panel provides rapid results to guide critical decisions about treatment and screening.